New Study Identifies Challenges for COVID-19 Vaccine Adoption

▴ New Study Identifies Challenges for COVID-19 Vaccine Adoption
Advisory firm Avenue Group® conducted a series of one-on-one, in-depth phone interviews with doctors, nurses, and members of the general public to better understand what needs to happen in order for Americans to feel comfortable choosing to take a COVID-19 vaccine.

Advisory firm Avenue Group® conducted a series of one-on-one, in-depth phone interviews with doctors, nurses, and members of the general public to better understand what needs to happen in order for Americans to feel comfortable choosing to take a COVID-19 vaccine.

The World Health Organization estimates that 65 to 75 percent of the population well over 200 million Americans need to have antibodies either by means of a vaccine or through recovery from the virus to reach herd immunity. Last month, Dr. Anthony Fauci said, "We know what the efficacy of the vaccines is, but its effectiveness will depend on how many people take the vaccine."

Avenue Group's research identified several areas that need to be addressed to increase the vaccination adoption rate. Avenue Group Founder Jeremy Greenberg said, "Only half of the participants told us that they are likely to take a COVID-19 vaccine. Vaccine safety and side effects are viewed as the most important factors driving the vaccination decision. Two-thirds of those not likely to take the vaccine doubt the safety of it. These are concerning issues that need to be addressed by policy leaders and health experts."

Several concerning themes emerged from Avenue Group's interviews: women are more often the gatekeepers for households and are less likely to take a COVID-19 vaccine than men, over one-third of doctors and nurses are not yet supportive of taking a vaccine, and some do not consider their doctor's recommendation important and are leery of new vaccines.

There were encouraging themes as well. President-elect Joe Biden's victory had a net positive impact on vaccination adoption. Half of Biden voters said that Biden's forthcoming oversight of distribution makes them more likely to take it, while Trump voters said that their vaccine decision is unaffected by who is president. Older and high-risk participants were more likely to take the vaccine. A 74-year-old retired participant from Port St. Lucie, Florida, said, "It makes sense for me. I'm older and I have a low immune system."

About the Study:

Avenue Group conducted confidential one-on-one interviews over the phone between November 13-23, 2020, during a surge in coronavirus cases across the U.S., and, after President-elect Joe Biden had been declared the winner of the presidential election. The average interview length was 30 minutes. The 40 participants in the study included 17 individuals from the medical community (11 doctors, six nurses) and 23 members of the general public.

The findings from this small study should be considered directional as this was not a large population study, and we prioritized deeper, live interactions over sample size. Participants constituted a diverse representation of American society, across gender, race, income, geography, employment status, level of education, political affiliation, and other demographic factors.

About Avenue Group: Avenue Group® advises private equity firms, Fortune 500s, mid-market companies, and non-profits. The company combines data with a firsthand narrative to drive smarter decisions with a primary research-first approach. Avenue Group sources conduct and analyze in-depth interviews and surveys to develop meaningful actionable insights for clients. The firm generates real-time market feedback to move beyond existing data and industry stereotypes.

Tags : #NewYork #America #AvenueGroup #WHO #Covid19 #Covid19VAccine #DrAnthonyFauci #FightAgainstVirus #Vaccination

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024